THE CANNABINOID RECEPTOR TYPE 2 AS MEDIATOR OF MESENCHYMAL STROMAL CELL IMMUNOSUPPRESSIVE PROPERTIES
Rossi F., Bellini G., Bernardo M., Luongo L., Guida F., Conforti A., Pianese J., Coppola M., Nobili B., de Novellis V., Di Marzo V., Locatelli F., Maione S. |
DENTAL PULP STEM CELLS AS NEW TOOL FOR STUDYING NEURODEGENERATIVE DISEASES
Di Scipio F., Sprio A., Salamone P., Gamba P., Testa G., Gargiulo S., Sottero B., Leonarduzzi G., Poli G., Berta G. |
MODIFICATION OF CASPASE GENE EXPRESSIONS IN THE CORTEX OF NEUROPATHIC MICE AFTER MESENCHYMAL STEM CELLS TRANSPLANTATION
Siniscalco D., Giordano C., Di Marsilio A., Alameen S., de Novellis V., Rossi F., Maione S. |
NEW THERAPEUTIC STRATEGIES FOR DOXORUBICIN-INDUCED DILATED CARDIOMYOPATHY
Esposito G., De Angelis A., Piegari E., Russo R., Cappetta D., Frati C., Quaini F., Urbanek K., Berrino L., Rossi F. |
INJURED MYOCARDIOCYTES PROMPT DENTAL PULP STEM CELLS MIGRATION AND EARLY HOMING IN ISCHEMIC HEARTS
Sprio A., Di Scipio F., Folino A., Carere M., Salamone P., Yang Z., Losano G., Rastaldo R., Berta G. |
PROPERTIES OF SMOOTH MUSCLE CELLS DIFFERENTIATED FROM HUMAN AMNIOTIC FLUID STEM CELLS
Ghionzoli M., Repele A., Sartiani L., Costanzi G., Spinelli V., David A., Garriboli M., Totonelli G., Tian J., Andreadis S., Cerbai E., Mugelli A., Messineo A., De Coppi P., Pierro A., Eaton S. |
GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN (GILZ) REGULATES HEMATOPOIETIC STEM CELL ENGRAFMENT AND MYELOID DIFFERENTIATION IN A MOUSE MODEL OF CEBPA MUTANT ACUTE MYELOID LEUKEMIA.
Frammartino T., Bereshchenko O., Sorcini D., Biagioli M., Cimino M., Venanzi A., Bruscoli S., Riccardi C. |
FRESH AND FROZEN MICRO-FRACTURED HUMAN ADIPOSE TISSUE GENERATES MESENCHYMAL STEM CELLS WITH HIGHER DIFFERENTIATION POTENTIAL AND IN VIVO REPAIR EFFICACY
Carelli S., Messaggio F., Giallongo T., Caremoli F., Hebda D., Colli M., Tremolada C., Trabucchi E., Di Giulio A., Gorio A. |
EXOGENOUS ADULT POST MORTEM NEURAL PRECURSORS ATTENUATE SECONDARY DEGENERATION, AND PROMOTE MYELIN SPARING AND FUNCTIONAL RECOVERY FOLLOWING EXPERIMENTAL SPINAL CORD INJURY
Marfia G., Carelli S., Merli D., Ottobrini L., Basso M., Di Giulio A., Gorio A. |
SORAFENIB INDUCES A SELECTIVE DEPLETION OF HUMAN GLIOBLASTOMA CANCER STEM CELLS BY DOWN-REGULATION OF MCL-1
Barbieri F., Mattioli F., Fucile C., Carra E., Marubbi D., Pattarozzi A., Wurth R., Gatti M., Favoni R., Daga A., Florio T. |
METFORMIN SELECTIVELY IMPAIRS CANINE MAMMARY CANCER STEM CELL SURVIVAL IN VITRO AND IN VIVO
Barbieri F., Thellung S., Wurth R., Daga A., Bajetto A., Ratto A., Ferrari A., Florio T. |
EUORPHAN: A WEBSITE COLLECTING INFORMATION ON DRUGS FOR RARE DISEASES
Giannuzzi V., Bartoloni F., Catapano M., Conte R., Felisi M., Ruggieri L., Ceci A. |
AN OVERVIEW OF THE ORPHAN MEDICINAL PRODUCTS LICENSED DURING THE FIRST 13 YEARS OF EU ORPHAN DRUG LEGISLATION
Roberto G., Biagi C., Buccellato E., Montanaro N. |
RECOMBINANT HUMAN LCAT NORMALIZES PLASMA LIPOPROTEIN PROFILE IN LCAT DEFICIENCY
Vitali C., Simonelli S., Tinti C., Salvini L., Tinti L., Ossoli A., Sousa V., Orsini G., Nolli M., Franceschini G., Calabresi L. |
NAPROXCINOD, A DUAL ACTING COMPOUND DONATING NITRIC OXIDE AND NAPROXEN, IS EFFECTIVE IN TWO MOUSE MODELS OF MUSCULAR DYSTROPHY
Miglietta D., Sciorati C., De Palma C., Ongini E., Clementi E. |
NEW HPLC–UV VALIDATED METHOD FOR THERAPEUTIC DRUG MONITORING OF ANTIFUNGAL AGENTS IN ACUTE MYELOID LEUKEMIA.
Cardalana P., De Francia S., Pirro E., Piccione F., Abbadessa G., Carriero V., Racca S., Poli G. |
LONG TERM TREATMENT WITH NAPROXCINOD, A NITRIC OXIDE-DONATING ANTI-INFLAMMATORY COMPOUND, SHOWS SIGNIFICANT THERAPEUTIC EFFECTS IN MDX MOUSE MODEL OF DYSTROPHY
Miglietta D., Uaesoontrachoon K., Quinn J., Tatem K., Creeden B., Vandermeulen J., Yu Q., Gordish H., Ongini E., Nagaraju K. |
